Kay See Tan
Kay See Tan
Verified email at
Cited by
Cited by
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
MR Rosenfeld, X Ye, JG Supko, S Desideri, SA Grossman, S Brem, ...
Autophagy 10 (8), 1359-1368, 2014
Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma
R Rangwala, YC Chang, J Hu, KM Algazy, TL Evans, LA Fecher, ...
Autophagy 10 (8), 1391-1402, 2014
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma
DT Vogl, EA Stadtmauer, KS Tan, DF Heitjan, LE Davis, L Pontiggia, ...
Autophagy 10 (8), 1380-1390, 2014
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
R Rangwala, R Leone, YC Chang, LA Fecher, LM Schuchter, A Kramer, ...
Autophagy 10 (8), 1369-1379, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment
A DeMichele, AS Clark, KS Tan, DF Heitjan, K Gramlich, M Gallagher, ...
Clinical Cancer Research 21 (5), 995-1001, 2015
A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti–PD-1 agent pembrolizumab
PS Adusumilli, MG Zauderer, I Rivière, SB Solomon, VW Rusch, ...
Cancer discovery 11 (11), 2748-2763, 2021
Trends in critical care beds and use among population groups and Medicare and Medicaid beneficiaries in the United States: 2000–2010
NA Halpern, DA Goldman, KS Tan, SM Pastores
Critical care medicine 44 (8), 1490-1499, 2016
Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program
AM McCarthy, D Kontos, M Synnestvedt, KS Tan, DF Heitjan, M Schnall, ...
Journal of the National Cancer Institute 106 (11), dju316, 2014
Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non–small-cell lung cancer: a competing risks analysis
T Eguchi, S Bains, MC Lee, KS Tan, B Hristov, DH Buitrago, MS Bains, ...
Journal of Clinical Oncology 35 (3), 281-290, 2017
Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score–matched analysis
T Eguchi, K Kameda, S Lu, MJ Bott, KS Tan, J Montecalvo, JC Chang, ...
Journal of thoracic oncology 14 (1), 87-98, 2019
The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder
MR Luskin, DS Heil, KS Tan, S Choi, EA Stadtmauer, SJ Schuster, ...
American Journal of Transplantation 15 (10), 2665-2673, 2015
Spread through air spaces (STAS) is an independent predictor of recurrence and lung cancer–specific death in squamous cell carcinoma
S Lu, KS Tan, K Kadota, T Eguchi, S Bains, N Rekhtman, PS Adusumilli, ...
Journal of Thoracic Oncology 12 (2), 223-234, 2017
Is enhanced recovery the new standard of care in microsurgical breast reconstruction?
A Afonso, S Oskar, KS Tan, JJ Disa, BJ Mehrara, J Ceyhan, JH Dayan
Plastic and reconstructive surgery 139 (5), 1053-1061, 2017
Safety and feasibility of lung resection after immunotherapy for metastatic or unresectable tumors
MJ Bott, J Cools-Lartigue, KS Tan, J Dycoco, MS Bains, RJ Downey, ...
The Annals of thoracic surgery 106 (1), 178-183, 2018
Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma
NP Chudgar, MF Brennan, RR Munhoz, PR Bucciarelli, KS Tan, ...
The Journal of thoracic and cardiovascular surgery 154 (1), 319-330. e1, 2017
The underlying tumor genomics of predominant histologic subtypes in lung adenocarcinoma
R Caso, F Sanchez-Vega, KS Tan, B Mastrogiacomo, J Zhou, GD Jones, ...
Journal of Thoracic Oncology 15 (12), 1844-1856, 2020
United States resource availability for COVID-19
NA Halpern, KS Tan
Society of Critical Care Medicine 3, 1-16, 2020
Pathologic assessment after neoadjuvant chemotherapy for NSCLC: importance and implications of distinguishing adenocarcinoma from squamous cell carcinoma
Y Qu, K Emoto, T Eguchi, RG Aly, H Zheng, JE Chaft, KS Tan, DR Jones, ...
Journal of Thoracic Oncology 14 (3), 482-493, 2019
Goal-directed fluid therapy using stroke volume variation for resuscitation after low central venous pressure-assisted liver resection: a randomized clinical trial
C Correa-Gallego, KS Tan, V Arslan-Carlon, M Gonen, SC Denis, ...
Journal of the American College of Surgeons 221 (2), 591-601, 2015
Interrater reliability of the patient education materials assessment tool (PEMAT)
J Vishnevetsky, CB Walters, KS Tan
Patient education and counseling 101 (3), 490-496, 2018
The system can't perform the operation now. Try again later.
Articles 1–20